Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease

Volume: 78, Issue: 11, Pages: 1270 - 1270
Published: Nov 1, 2021
Abstract
Anxiety is common among patients with coronary heart disease (CHD) and is associated with worse health outcomes; however, effective treatment for anxiety in patients with CHD is uncertain.To determine whether exercise and escitalopram are better than placebo in reducing symptoms of anxiety as measured by the Hospital Anxiety and Depression-Anxiety Subscale (HADS-A) and in improving CHD risk biomarkers.This randomized clinical trial was conducted...
Paper Details
Title
Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease
Published Date
Nov 1, 2021
Volume
78
Issue
11
Pages
1270 - 1270
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.